Clinical Trial Update: Handling Oxygenation Targets in COVID-19 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on handling oxygenation targets in COVID-19. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxemic Respiratory Failure
• Oxygen Toxicity

Snippet

Sponsor: Aalborg University Hospital | Conditions: Hypoxemic Respiratory Failure, Oxygen Toxicity | Phase 4 | Status: COMPLETED